SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ARIAD Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?


To: Henry Niman who wrote (417)1/4/1999 11:37:00 AM
From: Jongmans  Respond to of 4474
 
However without a press-release from Ariad and without (yet) articles in the big papers

Martin



To: Henry Niman who wrote (417)1/4/1999 3:10:00 PM
From: kaja  Read Replies (2) | Respond to of 4474
 
"AVGN" Patent on EPO Gene Therapy.

On 12/9/98 Avigen "AVGN" announced that it has been issued a broad patent covering ALL uses for EPO that is delivered using AAV vectors.

Would appreciate your comments relative to the AVGN patent on ARIAD.